English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

An expanded LUXendin color palette for GLP1R detection and visualization in vitro and in vivo

MPS-Authors
/persons/resource/persons244657

Podewin,  Tom
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons244947

Mathes,  Bettina
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons208663

Broichhagen,  Johannes
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Ast, J., Novak, A. N., Podewin, T., Fine, N. H., Jones, B., Tomas, A., et al. (2021). An expanded LUXendin color palette for GLP1R detection and visualization in vitro and in vivo. ChemRxiv, 1-23. doi:10.33774/chemrxiv-2021-7rngq.


Cite as: https://hdl.handle.net/21.11116/0000-0008-F3B3-B
Abstract
The glucagon-like peptide-1 receptor (GLP1R) is expressed in peripheral tissues and the brain, where it exerts pleiotropic actions on metabolic and inflammatory processes. Detection and visualization of GLP1R remains challenging, partly due to a lack of validated reagents. Previously, we generated LUXendins, antagonistic red and far-red fluorescent probes for specific labeling of GLP1R in live and fixed cells/tissue. We now extend this concept to the green and near-infrared color ranges by synthesizing and testing LUXendin492, LUXendin551, LUXendin615 and LUXendin762. All four probes brightly and specifically label GLP1R in cells and pancreatic islets. Further, LUXendin551 acts as chemical beta cell reporter in preclinical rodent models, while LUXendin762 allows non-invasive imaging, highlighting differentially-accessible GLP1R populations. We thus expand the color palette of LUXendins to seven different spectra, opening up a range of experiments using widefield microscopy available in most labs through super-resolution imaging and whole animal imaging. With this, we expect that LUXendins will continue to generate novel and specific insight into GLP1R biology.